Expression and Effects of JMJD2A Histone Demethylase in Endometrial Carcinoma |
Wang, Hong-Li
(Department of Obstetrics and Gynaecology, Second Affiliated Hospital of Harbin Medical University)
Liu, Mei-Mei (Department of Obstetrics and Gynaecology, Second Affiliated Hospital of Harbin Medical University) Ma, Xin (Department of Obstetrics and Gynaecology, Second Affiliated Hospital of Harbin Medical University) Fang, Lei (Department of Obstetrics and Gynaecology, Second Affiliated Hospital of Harbin Medical University) Zhang, Zong-Feng (Department of Obstetrics and Gynaecology, Second Affiliated Hospital of Harbin Medical University) Song, Tie-Fang (Department of Obstetrics and Gynaecology, Second Affiliated Hospital of Harbin Medical University) Gao, Jia-Yin (Department of Obstetrics and Gynaecology, Second Affiliated Hospital of Harbin Medical University) Kuang, Ye (Department of Obstetrics and Gynaecology, Second Affiliated Hospital of Harbin Medical University) Jiang, Jing (Department of Obstetrics and Gynaecology, Second Affiliated Hospital of Harbin Medical University) Li, Lin (Department of Obstetrics and Gynaecology, Second Affiliated Hospital of Harbin Medical University) Wang, Yang-Yang (Department of Obstetrics and Gynaecology, Second Affiliated Hospital of Harbin Medical University) Li, Pei-Ling (Department of Obstetrics and Gynaecology, Second Affiliated Hospital of Harbin Medical University) |
1 | Salvesen HB, Haldorsen IS, Trovik J (2012). Markers for individualised therapy in endometrial carcinoma. Lancet Oncol, 13, 353-61. DOI ScienceOn |
2 | Tsukada Y, Fang J, Erdjument-Bromage H, et al (2006). Histone demethylation by a family of JmjC domain-containing proteins. Nature, 439, 811-6. DOI |
3 | Vousden KH, and Prives C (2009). Blinded by the light: the growing complexity of p53. Cell, 137, 413-31. DOI ScienceOn |
4 | Wang XW, Chen YL, Luo YL, Liu QY (2011). No association between the CYP1B1 C4326G polymorphism and endometrial cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 12, 2343-8. |
5 | Qin C, Nguyen T, Stewart J, et al (2002). Estrogen up-regulation of p53 gene expression in MCF-7 breast cancer cells is mediated by calmodulin kinase IV-dependent activation of anuclearfactorB/CCAAT- bindingtranscriptionfactor-1complex. Mol Endocrinol, 16, 1793-809. DOI ScienceOn |
6 | Ryan AJ, Susil B, Jobling TW, Oehler MK (2005). Endometrial cancer. Cell and Tissue Research, 322, 53-61. DOI |
7 | Shah YM, Basrur V, Rowan BG (2004). Selective estrogen receptor modulator regulated proteins in endometrial cancer cells. Mol Cell Endocrinol, 219, 127-39. DOI ScienceOn |
8 | Shin S, Janknecht R (2007). Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem Biophys Res Commun, 359, 742-6. DOI ScienceOn |
9 | Shirley SH, Rundhaug JE, Tian J, et al (2009). Transcriptional regulation of estrogen receptor by p53 in human breast cancer cells. Cancer Res, 69, 3405-14. DOI ScienceOn |
10 | Siegel R, Naishadham D, Jemal A (2013). Cancer statistics. CA Cancer J Clin, 63, 11-30. DOI ScienceOn |
11 | Sirbasku DA, Moreno-Cuevas JE (2000). Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications. In Vitro Cell Dev Biol Anim, 36, 428-46. DOI |
12 | Soto AM, Sonnenschein C (1987). Cell proliferation of estrogen-sensitive cells: the case for negative control. Endocr Rev, 8, 44-52. DOI ScienceOn |
13 | Thanapprapasr D, Thanapprapasr K (2013). Molecular therapy as a future strategy in endometrial cancer. Asian Pac J Cancer Prev, 14, 3419-23. 과학기술학회마을 DOI ScienceOn |
14 | Thomas DB (1984). Do hormones cause breast cancer? Cancer, 53, 595-604. DOI |
15 | Cloos PA, Christensen J, Agger K, et al (2006). The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature, 442, 307-11. DOI ScienceOn |
16 | Di Cristofano A, Ellenson LH (2007). Endometrial carcinoma. Ann Rev Pathol, 2, 57-85. DOI ScienceOn |
17 | Berstein LM, Tchernobrovkina AE, Gamajunova VB, et al (2003). Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer. J Cancer Res Clin Oncol, 129, 245-9. |
18 | Chao A, Wang TH, Lee YS, et al (2006). Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer, 119, 91-8. DOI ScienceOn |
19 | Dickson RB, Lippman ME (1995). Growth factors in breast cancer. Endocr Rev, 16, 559-89. DOI |
20 | Hecht JL, Mutter GL (2006). Molecular and pathologic aspects ofendometrial carcinogenesis. J Clin Oncol, 24, 4783-91. DOI ScienceOn |
21 | Katoh M, Katoh M (2004). Identification and characterization of JMJD2 family genes in silico. Int J Oncol, 24, 1623-8. |
22 | Angeloni SV, Martin MB, Garcia-Morales P, Castro-Galache MD, et al (2004). Regulation of estrogen receptor-alpha expression by the tumor suppressor gene p53 in MCF-7 cells. J Endocrinol, 180, 497-504. DOI ScienceOn |
23 | Kauffman EC, Robinson BD, Downes MJ, et al (2011). Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol Carcinog, 50, 931-44. DOI ScienceOn |
24 | Kim TD, Shin S, Berry WL, et al (2012). The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells. J Cell Biochem, 113, 1368-76. DOI ScienceOn |
25 | Amant F, Moerman P, Neven P, et al (2005). Endometrial cancer. Lancet, 366, 491-505. DOI ScienceOn |
26 | Arafa M, Somja J, Dehan P, Kridelka F, Goffin F, et al (2010). Current concepts in the pathology and epigenetics of endometrial carcinoma. Pathology, 42, 613-7. DOI ScienceOn |
27 | Berger CE, Qian Y, Liu G, Chen H, Chen X (2012). p53, a target of estrogen receptor (ER), modulates DNA damage-induced growth suppression in ER-positivebreast cancer cells. J Biol Chem, 287, 30117-27. DOI |
28 | Berry WL, Shin S, Lightfoot SA, Janknecht R (2012). Oncogenic features of the JMJD2A histone demethylase in breast cancer. Int J Oncol, 41, 1701-6. DOI |
29 | Li BX, Zhang MC, Luo CL, et al (2011). Effects of RNA interference-mediated gene silencing of JMJD2A on human breast cancer cell line MDA-MB-231 in vitro. J Exp Clin Cancer Res, 30, 90. DOI |